Mutations affecting TNFRSF13B are found in 8% of CVID patients, however they are also found in 2% of the normal population (24), indicating that TNFRSF13B is a genetic risk factor for CVID, with disease expression presumably dependent on genetic modifiers or environmental triggers. The gene discussed is TNFRSF13B; the disease is common variable immunodeficiency.